Skip to main content
×
Home
    • Aa
    • Aa

Aprotinin; friend or foe? A review of recent medical literature

  • D. Royston (a1), N. van Haaften (a1) and P. De Vooght (a1)
Abstract

Summary

Recent articles published in peer review journals have questioned the safety of using aprotinin in patients having heart surgery. Also, evidence has been published to suggest an increase in renal events in patients given aprotinin when compared to those where tranexamic acid was used. The present review will focus principally on the first of these articles in relation to previously published data and experience.

Copyright
Corresponding author
Correspondence to: David Royston, Department of Anaesthesia and Critical Care, Royal Brompton and Harefield NHS Trust, Harefield Hospital, Hill End Road, Harefield, Middlesex, UB9 6JH, UK. E-mail: dave@tharg.demon.co.uk; Tel: +44 1895 828946; Fax: +44 1895 828965
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

ManganoDT, TudorIC, DietzelC. The risk associated with aprotinin in cardiac surgery.New Engl J Med2006; 354(4): 353365.

HunterD. First, gather the data.New Engl J Med2006; 354(4): 329331.

VlahakesGJ. The value of phase 4 clinical testing.New Engl J Med2006; 354(4): 413415.

KarkoutiK, BeattieWS, DattiloKMet al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.Transfusion2006; 46(3): 327338.

SedrakyanA, TreasureT, ElefteriadesJA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials.J Thorac Cardiovasc Surg2004; 128(3): 442448.

SamamaCM, LangeronO, RosencherNet al. Aprotinin versus placebo in major orthopedic surgery: a randomized, double-blinded, dose-ranging study.Anesth Analg2002; 95(2): 287293, table of contents.

BedirhanMA, TurnaA, YaganN, TasciO. Aprotinin reduces postoperative bleeding and the need for blood products in thoracic surgery: results of a randomized double-blind study.Eur J Cardiothorac Surg2001; 20(6): 11221127.

LentschenerC, BenhamouD, MercierFJet al. Aprotinin reduces blood loss in patients undergoing elective liver resection.Anesth Analg1997; 84(4): 875881.

PorteRJ, SlooffMJ. Aprotinin: safe and effective in all patients undergoing orthotopic liver transplantation?Liver Transpl2001; 7(9): 808810.

CosgroveDd, HericB, LytleBW, et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study.Ann Thorac Surg1992; 54(6): 10311036.

LevyJH, PifarreR, SchaffHVet al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.Circulation1995; 92(8): 22362244.

LemmerJrJH, DillingEW, MortonJRet al. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens [see comments].Ann Thorac Surg1996; 62(6): 16591667.

AldermanEL, LevyJH, RichJBet al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.J Thorac Cardiovasc Surg1998; 116(5): 716730.

RoystonD, LevyJH, FitchJet al. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcome.Anesth Analg2006; 103: 10821088.

LemmerJrJH, StanfordW, BonneySLet al. Aprotinin for coronary artery bypass grafting: effect on postoperative renal function.Ann Thorac Surg1995; 59(1): 132136.

MercieriM, MercieriA, TritapepeLet al. High-dose aprotinin with gentamicin–vancomycin antibiotic prophylaxis increases blood concentrations of creatinine and cystatin C in patients undergoing coronary artery bypass grafting.Br J Anaesth1999; 82(4): 531536.

GoldsteinDJ, SeldomridgeJA, ChenJMet al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality.Ann Thorac Surg1995; 59(5): 10631067.

BidstrupBP, HarrisonJ, RoystonD, TaylorKM, TreasureT. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom.Ann Thorac Surg1993; 55(4): 971976.

SchweizerA, HohnL, MorelDR, KalangosA, LickerM. Aprotinin does not impair renal haemodynamics and function after cardiac surgery [see comments].Br J Anaesth2000; 84(1): 1622.

ManganoDT. Aspirin and mortality from coronary bypass surgery.New Engl J Med2002; 347(17): 13091317.

MathewJP, FontesML, TudorICet al. A multicenter risk index for atrial fibrillation after cardiac surgery.JAMA2004; 291(14): 17201729.

ManganoCM, DiamondstoneLS, RamsayJG, AggarwalA, HerskowitzA, ManganoDT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group.Ann Intern Med1998; 128(3): 194203.

BuceriusJ, GummertJF, WaltherTet al. On-pump versus off-pump coronary artery bypass grafting: impact on postoperative renal failure requiring renal replacement therapy.Ann Thorac Surg2004; 77(4): 12501256.

AntunesPE, PrietoD, Ferrao de OliveiraJ, AntunesMJ. Renal dysfunction after myocardial revascularization.Eur J Cardiothorac Surg2004; 25(4): 597604.

KuitunenA, VentoA, Suojaranta-YlinenR, PettilaV. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification.Ann Thorac Surg2006; 81(2): 542546.

ConlonPJ, Stafford-SmithM, WhiteWDet al. Acute renal failure following cardiac surgery.Nephrol Dial Transpl1999; 14(5): 11581162.

Mora ManganoCT, NevilleMJ, HsuPH, MigneaI, KingJ, MillerDC. Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest.Circulation2001; 104(12 Suppl 1): I276I281.

BrownJ, BirkmeyerN, O'ConnorJ. Aprotinin in cardiac surgery.New Engl J Med2006; 354(18): 19531957.

HabibRH, ZachariasA, SchwannTAet al. Role of hemodilutional anemia and transfusion during cardiopulmonary bypass in renal injury after coronary revascularization: implications on operative outcome.Crit Care Med2005; 33(8): 17491756.

KochCG, LiL, DuncanAIet al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival.Ann Thorac Surg2006; 81(5): 16501657.

EngorenMC, HabibRH, ZachariasA, SchwannTA, RiordanCJ, DurhamSJ. Effect of blood transfusion on long-term survival after cardiac operation.Ann Thorac Surg2002; 74(4): 11801186.

KuduvalliM, OoAY, NewallNet al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery.Eur J Cardiothorac Surg2005; 27(4): 592598.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

European Journal of Anaesthesiology
  • ISSN: 0265-0215
  • EISSN: 1365-2346
  • URL: /core/journals/european-journal-of-anaesthesiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Abstract views

Total abstract views: 46 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd May 2017. This data will be updated every 24 hours.